Erin F. Pinnell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erin F. Pinnell has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Kathryn J. Timko
The Ohio State University College of Veterinary Medicine , Columbus, Ohio
2 shared publications Laura D. Hostnik
The Ohio State University College of Veterinary Medicine , Columbus, Ohio
2 shared publicationsMauria R. Watts
The Ohio State University College of Veterinary Medicine , Columbus, Ohio
2 shared publications- Ramiro E. Toribio
College of Veterinary Medicine, The Ohio State University, 601 Vernon Tharp Street, Columbus, OH 43210, USA
2 shared publications - Teresa A. Burns
The Ohio State University College of Veterinary Medicine , Columbus, Ohio
2 shared publications Allison A. Thriffiley
The Ohio State University College of Veterinary Medicine Department of Veterinary Clinical Sciences Columbus, Ohio
1 shared publication
Latest Publications
- Open Access
- 2 March 2026
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (2)
Relationship between prevalence and severity of exercise-induced pulmonary hemorrhage and environmental factors
Environmental risk factors could contribute to the development of exercise-induced pulmonary hemorrhage (EIPH) in racing Thoroughbreds. To identify environmental risk factors that might contribute to differences in EIPH prevalence and severity across 12 Thoroughbred racetracks in the United States. Eight hundred fifteen 2-year-old and 122 >2-year-old Thoroughbred racehorses. Prospective blinded observational study. Videoendoscopy was performed 30-60 min post-race. Three observers independently assigned an EIPH grade to each videorecording, and prevalence and severity of EIPH were determined. Multivariable logistic regression assessed relationships between EIPH prevalence and severity, respectively, and independent variables including furosemide administration, race distance and surface, and lifetime race number (LRN). P ≤ .05 was considered significant. One thousand one hundred ninety-two videorecordings received EIPH severity grades from 12 racetracks in 10 different states and 3 time zones. Ambient temperature (AT) was negatively associated with EIPH prevalence (OR = 0.82, 95% CI, 0.69-0.98; P = .03) and severity (OR = 0.79, 95% CI, 0.63-0.99; P = .04). Furosemide administration (OR = 0.04, 95% CI, 0.006-0.33; P = .002), turf (OR = 0.64, 95% CI, 0.43-0.95; P = .027) and all weather (OR = 0.03, 95% CI, 0.004-0.26; P = .001) track surfaces, and LRN (OR = 1.07, 95% CI, 1.01-1.12; P = .012) were associated with occurrence of EIPH. Two-year-olds racing in bad air (air quality index [AQI] > 100) had more severe EIPH than those racing in AQI < 50 (OR = 2.78, 95% CI, 1.06-7.29; P = .04). AT, AQI, LRN, and surface type might be associated with EIPH prevalence and severity between American racetracks.
- 2 March 2026
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (2)
Open AccessRelationship between prevalence and severity of exercise-induced pulmonary hemorrhage and environmental factors
Environmental risk factors could contribute to the development of exercise-induced pulmonary hemorrhage (EIPH) in racing Thoroughbreds. To identify environmental risk factors that might contribute to differences in EIPH prevalence and severity across 12 Thoroughbred racetracks in the United States. Eight hundred fifteen 2-year-old and 122 >2-year-old Thoroughbred racehorses. Prospective blinded observational study. Videoendoscopy was performed 30-60 min post-race. Three observers independently assigned an EIPH grade to each videorecording, and prevalence and severity of EIPH were determined. Multivariable logistic regression assessed relationships between EIPH prevalence and severity, respectively, and independent variables including furosemide administration, race distance and surface, and lifetime race number (LRN). P ≤ .05 was considered significant. One thousand one hundred ninety-two videorecordings received EIPH severity grades from 12 racetracks in 10 different states and 3 time zones. Ambient temperature (AT) was negatively associated with EIPH prevalence (OR = 0.82, 95% CI, 0.69-0.98; P = .03) and severity (OR = 0.79, 95% CI, 0.63-0.99; P = .04). Furosemide administration (OR = 0.04, 95% CI, 0.006-0.33; P = .002), turf (OR = 0.64, 95% CI, 0.43-0.95; P = .027) and all weather (OR = 0.03, 95% CI, 0.004-0.26; P = .001) track surfaces, and LRN (OR = 1.07, 95% CI, 1.01-1.12; P = .012) were associated with occurrence of EIPH. Two-year-olds racing in bad air (air quality index [AQI] > 100) had more severe EIPH than those racing in AQI < 50 (OR = 2.78, 95% CI, 1.06-7.29; P = .04). AT, AQI, LRN, and surface type might be associated with EIPH prevalence and severity between American racetracks.
- Open Access
- 1 March 2025
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 39 (2) , e17305
Corticosteroid Administration Enhances the Glycemic, Insulinemic, and Incretin Responses to a High-Protein Mixed Meal in Adult Horses
Background: Corticosteroids are used routinely in horses and induce insulin dysregulation (ID). Nutrition is important for ID management and includes low nonstructural carbohydrate (NSC) diets and, often, high-protein ration balancers (RB). Insulin and incretin secretion increase after high-protein meals; corticosteroids may influence these effects. Hypothesis: A high-protein mixed meal will induce hyperinsulinemia and increased concentrations of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) in horses with ID; dexamethasone (DEX) will amplify this effect. Animals: Five horses with naturally occurring ID. Methods: Horses underwent an IV glucose tolerance test and a feed challenge test (FCT; 1 kg RB). Tests were repeated after DEX administration (0.08 mg/kg PO q24h, 7 days). Insulin, glucose, and incretin dynamics were compared pre- and post-DEX. Results: Corticosteroids exacerbated post-prandial hyperinsulinemia and hyperglycemia after a high-protein meal. The FCT area under the curve for insulin (AUCINS) after DEX was significantly higher than baseline (558 ± 182 μIU/mL × min vs. 257 ± 93.9 μIU/mL × min; p = 0.03). The maximum concentration of GIP (CmaxGIP) after DEX (381 ± 70.6 pg/mL) was significantly higher than baseline (262 ± 13.7 pg/mL; p = 0.013). The AUC for GLP-1 (AUCGLP-1; 31.1 ± 15.2 vs. 50 ± 20.2 pg/mL; p = 0.19) and the Cmax of GLP-1 (CmaxGLP-1; 39.1 ± 25.3 vs. 29.6 ± 12.2 pg/mL; p = 0.32) did not differ between DEX and baseline. Conclusions and Clinical Importance: Metabolic responses to a high-protein mixed meal were exacerbated by corticosteroids. Horses receiving corticosteroids had larger GIP responses, which may enhance post-prandial hyperinsulinemia.
- 1 March 2025
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 39 (2) , e17305
Open AccessCorticosteroid Administration Enhances the Glycemic, Insulinemic, and Incretin Responses to a High-Protein Mixed Meal in Adult Horses
Background: Corticosteroids are used routinely in horses and induce insulin dysregulation (ID). Nutrition is important for ID management and includes low nonstructural carbohydrate (NSC) diets and, often, high-protein ration balancers (RB). Insulin and incretin secretion increase after high-protein meals; corticosteroids may influence these effects. Hypothesis: A high-protein mixed meal will induce hyperinsulinemia and increased concentrations of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) in horses with ID; dexamethasone (DEX) will amplify this effect. Animals: Five horses with naturally occurring ID. Methods: Horses underwent an IV glucose tolerance test and a feed challenge test (FCT; 1 kg RB). Tests were repeated after DEX administration (0.08 mg/kg PO q24h, 7 days). Insulin, glucose, and incretin dynamics were compared pre- and post-DEX. Results: Corticosteroids exacerbated post-prandial hyperinsulinemia and hyperglycemia after a high-protein meal. The FCT area under the curve for insulin (AUCINS) after DEX was significantly higher than baseline (558 ± 182 μIU/mL × min vs. 257 ± 93.9 μIU/mL × min; p = 0.03). The maximum concentration of GIP (CmaxGIP) after DEX (381 ± 70.6 pg/mL) was significantly higher than baseline (262 ± 13.7 pg/mL; p = 0.013). The AUC for GLP-1 (AUCGLP-1; 31.1 ± 15.2 vs. 50 ± 20.2 pg/mL; p = 0.19) and the Cmax of GLP-1 (CmaxGLP-1; 39.1 ± 25.3 vs. 29.6 ± 12.2 pg/mL; p = 0.32) did not differ between DEX and baseline. Conclusions and Clinical Importance: Metabolic responses to a high-protein mixed meal were exacerbated by corticosteroids. Horses receiving corticosteroids had larger GIP responses, which may enhance post-prandial hyperinsulinemia.
- Open Access
- 1 July 2024
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 38 (4) , 2399-2403
Successful hemodialysis treatment of a Quarter Horse mare with silver maple leaf toxicity and acute kidney injury
An adult American Quarter Horse mare presented for pigmenturia and lethargy of 12 hours' duration and was diagnosed with silver maple leaf toxicity. The mare had intravascular hemolysis and azotemia. The mare was treated with a transfusion of whole blood, fluids administered IV, antibiotics, oxygen insufflation, and supportive care. The azotemia persisted despite conventional medical management and hemodialysis was elected. After 2 intermittent hemodialysis treatments over 3 days, the azotemia almost resolved, clinical signs improved, and the mare was discharged. The blood urea nitrogen, creatinine, and electrolyte concentrations remained normal 6 months later after examination by the referring veterinarian. Hemodialysis treatment can be feasible in horses if equipment and expertise are available and should be considered as a treatment option if indicated.
- 1 July 2024
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 38 (4) , 2399-2403
Open AccessSuccessful hemodialysis treatment of a Quarter Horse mare with silver maple leaf toxicity and acute kidney injury
An adult American Quarter Horse mare presented for pigmenturia and lethargy of 12 hours' duration and was diagnosed with silver maple leaf toxicity. The mare had intravascular hemolysis and azotemia. The mare was treated with a transfusion of whole blood, fluids administered IV, antibiotics, oxygen insufflation, and supportive care. The azotemia persisted despite conventional medical management and hemodialysis was elected. After 2 intermittent hemodialysis treatments over 3 days, the azotemia almost resolved, clinical signs improved, and the mare was discharged. The blood urea nitrogen, creatinine, and electrolyte concentrations remained normal 6 months later after examination by the referring veterinarian. Hemodialysis treatment can be feasible in horses if equipment and expertise are available and should be considered as a treatment option if indicated.
- Open Access
- 1 January 2024
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 38 (1) , 102-110
Effect of 5′-adenosine monophosphate-activated protein kinase agonists on insulin and glucose dynamics in experimentally induced insulin dysregulation in horses
Background: 5′-adenosine monophosphate-activated protein kinase (AMPK) agonists, particularly resveratrol (RES), have not been extensively evaluated for their effect on insulin dysregulation (ID) in horses. Objectives: Evaluate the effects of treatment with RES (10 mg/kg PO q12h), metformin (MET; 30 mg/kg PO q12h), and aspirin (ASP; 20 mg/kg PO q24h) on experimentally induced ID. Animals: Thirty-three healthy, adult, light-breed horses. Methods: Unblinded, placebo-controlled, experimental trial evaluating effects of AMPK agonists (RES, MET, and ASP) on experimentally induced ID. Horses were randomly assigned to a treatment group (RES, MET/ASP, RES/ASP, RES/MET/ASP, or placebo [CON]) after induction of ID with dexamethasone (0.08 mg/kg PO q24h for 7 days). Frequently sampled insulin-modified IV glucose tolerance tests (FSIGTT) and oral sugar tests (OST) were performed at baseline, 7 days after ID, and ID plus 7 days of treatment. Minimal model and OST variables were compared between (1-way ANOVA) and within (1-way ANOVA for repeated measures) groups over time to determine effects of treatment on ID. Results: Administration of dexamethasone for 14 days resulted in significantly altered insulin and glucose dynamics (SI, DI, basal [glucose], and [insulin]) and produced clinical signs of laminitis in 5 out of 33 (15%) of horses included in the study. Combination therapy with RES, MET, and ASP did not significantly improve insulin and glucose dynamics in horses with experimentally induced ID. Conclusions and Clinical Importance: Metabolic testing before glucocorticoid administration should be considered in horses with clinical signs of metabolic syndrome.
- 1 January 2024
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 38 (1) , 102-110
Open AccessEffect of 5′-adenosine monophosphate-activated protein kinase agonists on insulin and glucose dynamics in experimentally induced insulin dysregulation in horses
Background: 5′-adenosine monophosphate-activated protein kinase (AMPK) agonists, particularly resveratrol (RES), have not been extensively evaluated for their effect on insulin dysregulation (ID) in horses. Objectives: Evaluate the effects of treatment with RES (10 mg/kg PO q12h), metformin (MET; 30 mg/kg PO q12h), and aspirin (ASP; 20 mg/kg PO q24h) on experimentally induced ID. Animals: Thirty-three healthy, adult, light-breed horses. Methods: Unblinded, placebo-controlled, experimental trial evaluating effects of AMPK agonists (RES, MET, and ASP) on experimentally induced ID. Horses were randomly assigned to a treatment group (RES, MET/ASP, RES/ASP, RES/MET/ASP, or placebo [CON]) after induction of ID with dexamethasone (0.08 mg/kg PO q24h for 7 days). Frequently sampled insulin-modified IV glucose tolerance tests (FSIGTT) and oral sugar tests (OST) were performed at baseline, 7 days after ID, and ID plus 7 days of treatment. Minimal model and OST variables were compared between (1-way ANOVA) and within (1-way ANOVA for repeated measures) groups over time to determine effects of treatment on ID. Results: Administration of dexamethasone for 14 days resulted in significantly altered insulin and glucose dynamics (SI, DI, basal [glucose], and [insulin]) and produced clinical signs of laminitis in 5 out of 33 (15%) of horses included in the study. Combination therapy with RES, MET, and ASP did not significantly improve insulin and glucose dynamics in horses with experimentally induced ID. Conclusions and Clinical Importance: Metabolic testing before glucocorticoid administration should be considered in horses with clinical signs of metabolic syndrome.